Within-patient genetic diversity of SARS-CoV-2

Jack Kuipers, Aashil A. Batavia, Kim Philipp Jablonski, Fritz Bayer, Nico Borgsmüller, Arthur Dondi, Monica-Andreea Drăgan, Pedro Ferreira, Katharina Jahn, Lisa Lamberti, Martin Pirkl, Susana Posada-Céspedes, Ivan Topolsky, Ina Nissen, Natascha Santacroce, Elodie Burcklen, Tobias Schär, Vincenzo Capece, Christiane Beckmann, Olivier Kobel, Christoph Noppen, Maurice Redondo, Sarah Nadeau, Sophie Seidel, Noemie Santamaria de Souza, Christian Beisel, Tanja Stadler, Niko BeerenwinkelbioRxiv 2020 · DOI

Abstract

SARS-CoV-2, the virus responsible for the COVID-19 pandemic, evolves into different genetic variants by accumulating mutations as it spreads globally. Beyond the diversity of consensus genomes across patients, RNA viruses can also display significant genetic diversity within individual hosts. This study systematically examines the intra-patient genetic diversity of SARS-CoV-2 using a large cohort of 3,939 publicly available deeply sequenced genomes and 749 samples from Switzerland. We found that the distribution of diversity across patients and genomic loci is highly unbalanced, with a minority of hosts and positions accounting for most of the variation. Notably, the D614G variant in the Spike gene exhibits high intra-host diversity in nearly 30% of the public cohort. Furthermore, patient age was identified as a significant predictor of viral genetic diversity, suggesting that older individuals may harbor more diverse viral populations.

Introduction: The Viral Swarm

Most genomic studies of SARS-CoV-2 focus on the "consensus" sequence—the dominant version of the virus found in a patient. However, RNA viruses like SARS-CoV-2 are notorious for their high mutation rates, often existing within a single host as a collection of closely related variants known as a quasispecies. Understanding this intra-patient diversity is critical because co-existing variants can influence disease progression, transmission dynamics, and the potential for immune evasion or resistance to medical treatments. This research provides a large-scale survey of this "internal" diversity across thousands of patients.

Methods and Pipeline

The researchers utilized a specialized bioinformatics pipeline called V-pipe to process raw deep-sequencing data. Unlike standard tools that identify only the dominant sequence, V-pipe is designed to call low-frequency single-nucleotide variants (SNVs)—mutations appearing in only a small percentage of the viral population within a patient.

V-pipe workflow and genomic distribution of SNVs

To quantify diversity, Shannon entropy was calculated for every position in the viral genome. This metric allows researchers to distinguish between highly conserved sites (low entropy) and "hotspots" where multiple variants coexist (high entropy). Regression modeling was then used to determine if epidemiological factors like age or sex could predict viral mutation levels, while carefully controlling for technical noise such as sequencing depth and error rates.

Datasets

The study analyzed two major cohorts:

  1. Public Cohort: 3,939 deeply sequenced genomes retrieved from the Sequence Read Archive (SRA), primarily using Illumina technology.
  2. Swiss Cohort: 749 recently sequenced samples from Switzerland, serving as an independent validation set.

Key Insights: Hotspots and the Age Factor

The analysis revealed several critical patterns in how SARS-CoV-2 diversifies within its host:

  • The "Heavy Tail" Distribution: Viral diversity is not spread evenly. A small minority of patients and specific genomic locations account for the vast majority of observed genetic variation.
  • The Age Factor: The most striking finding is that viral genetic diversity increases with the age of the patient. The model predicts an 8.6% increase in total entropy for every decade of age, suggesting that in older patients, the virus has more opportunity to diversify, possibly due to a slower or less effective immune response.
  • D614G Coexistence: The famous D614G mutation in the Spike protein, known for increasing infectivity, is not always fixed. In nearly 30% of the public cohort, the researchers found both the original and mutated variants co-existing within the same individual.
Entropy heatmaps showing diversity hotspots across samples and genomic positions

Key Results

  • Age as a Predictor: Age was a significant predictor of diversity ($p = 4 \times 10^{-4}$), a finding corroborated in the Swiss cohort using sequencing date as a proxy for age.
  • Gene-Specific Diversity: The Matrix (M) gene was found to be the most diverse on average, while ORF7b was the most stable.
  • Mutation Frequencies: At the most diverse site (position 11075), nearly half of the samples showed some level of mutation, frequently involving low-frequency deletions that could alter the resulting protein.
  • Technical Robustness: While sequencing technology affects detection sensitivity, the biological signal regarding age remained consistent across different platforms.

Limitations and Future Outlook

Detecting subclonal mutations is highly sensitive to sequencing depth and potential artifacts from PCR amplification. While the researchers adjusted for these technical parameters, "noise" remains an inherent challenge in deep-sequencing studies.

A major remaining question is causality: Does higher viral diversity drive the worse clinical outcomes seen in the elderly, or is the diversity simply a result of a less effective immune system allowing the virus to replicate and mutate longer? Future research integrating high-quality clinical data with these genetic profiles will be essential to determine if "internal" viral evolution can be used to predict disease severity or transmission risk.

Summary updated

Abstract

Abstract SARS-CoV-2, the virus responsible for the current COVID-19 pandemic, is evolving into different genetic variants by accumulating mutations as it spreads globally. In addition to this diversity of consensus genomes across patients, RNA viruses can also display genetic diversity within individual hosts, and co-existing viral variants may affect disease progression and the success of medical interventions. To systematically examine the intra-patient genetic diversity of SARS-CoV-2, we processed a large cohort of 3939 publicly-available deeply sequenced genomes with specialised bioinformatics software, along with 749 recently sequenced samples from Switzerland. We found that the distribution of diversity across patients and across genomic loci is very unbalanced with a minority of hosts and positions accounting for much of the diversity. For example, the D614G variant in the Spike gene, which is present in the consensus sequences of 67.4% of patients, is also highly diverse within hosts, with 29.7% of the public cohort being affected by this coexistence and exhibiting different variants. We also investigated the impact of several technical and epidemiological parameters on genetic heterogeneity and found that age, which is known to be correlated with poor disease outcomes, is a significant predictor of viral genetic diversity. Author Summary Since it arose in late 2019, the new coronavirus (SARS-CoV-2) behind the COVID-19 pandemic has mutated and evolved during its global spread. Individual patients may host different versions, or variants, of the virus, hallmarked by different mutations. We examine the diversity of genetic variants coexisting within patients across a cohort of 3939 publicly accessible samples and 749 recently sequenced samples from Switzerland. We find that a small number of patients carry most of the diversity, and that patients with more diversity tend to be older. We also find that most of the diversity is concentrated in certain regions and positions of the virus genome. In particular, we find that a variant reported to increase infectivity is among the most diverse positions. Our study provides a large-scale survey of within-patient diversity of the SARS-CoV-2 genome.
BibTeX
@misc{kuipers2020within,
  author = {Jack Kuipers and Aashil A. Batavia and Kim Philipp Jablonski and Fritz Bayer and Nico Borgsmüller and Arthur Dondi and Monica-Andreea Drăgan and Pedro Ferreira and Katharina Jahn and Lisa Lamberti and Martin Pirkl and Susana Posada-Céspedes and Ivan Topolsky and Ina Nissen and Natascha Santacroce and Elodie Burcklen and Tobias Schär and Vincenzo Capece and Christiane Beckmann and Olivier Kobel and Christoph Noppen and Maurice Redondo and Sarah Nadeau and Sophie Seidel and Noemie Santamaria de Souza and Christian Beisel and Tanja Stadler and Niko Beerenwinkel},
  title = {{Within-patient genetic diversity of SARS-CoV-2}},
  year = {2020},
  doi = {10.1101/2020.10.12.335919},
  howpublished = {bioRxiv},
}
Figure